Bavisant

• CAT Number: I003958
• CAS Number: 929622-08-2(free base)
• Molecular Formula: C19H27N3O2
• Molecular Weight: 329.44
• Purity: ≥95%
• Synonyms: JNJ-31001074; JNJ31001074; JNJ 31001074; Bavisant.;(4-cyclopropylpiperazin-1-yl)(4-(morpholinomethyl)phenyl)methanone
• Target: Neuronal Signaling
• Solubility: Soluble in DMSO, not in water
• Storage: 0 - 4 °C for short term or -20 °C for long term
• IUPAC Name: (4-cyclopropylpiperazin-1-yl)-[4-(morpholin-4-ylmethyl)phenyl]methanone
• InChI: 1S/C19H27N3O2/c23-19(22-9-7-21(8-10-22)18-5-6-18)17-3-1-16(2-4-17)15-20-11-13-24-14-12-20/h1-4,18H,5-15H2
• InChIKey: BGBVSGSIXIIREO-UHFFFAOYSA-N
• SMILES: O=C(N1CCN(C2CC2)CC1)C3=CC=C(CN4CCOCC4)C=C3

Bavisant(CAT: I003958) is a selective histamine H3 receptor antagonist/inverse agonist, widely utilized in neurological and cognitive research. By modulating H3 receptor activity, it enhances the release of neurotransmitters such as histamine, dopamine, and acetylcholine, making it valuable for studying conditions related to cognitive impairment, attention deficit disorders, and sleep-wake regulation. Bavisant is also explored for its potential therapeutic applications in neurodegenerative diseases, such as Alzheimer’s and Parkinson’s disease. Its high specificity and efficacy make it a critical tool in preclinical studies aimed at developing treatments for neurological and psychiatric disorders.